BOSTON MEGAN (Executive Director) purchased 25.91K shares of BENITEC BIOPHARMA INC. on the open market
Open‑market purchases signal personal conviction.
P · 1 purchase
Filed: 8/14/2023ACC: 0000899243-23-018119
DirectorOfficer· Executive Director
Since Apr 2020
+51.81K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
51.81K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.91K
Price / share
—
Trade value
—
% of position
New position
8/11/2023
0.00→25.91K
Total
Net shares
+25.91K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2023 | P · Purchase | +25.91K | — | — | New position | 0.00 | 25.91K |
| Total | +25.91K | $0.00 | ||||||
Derivative Transactions1
Common Warrants (right to buy)
Direct
Converts to
Common Stock
25.91K shares
Shares
+25.91K
Strike price
3.86
Held after
25.91K
Exercisable
—
8/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Warrants (right to buy) Direct | Common Stock25.91K shares | 8/11/2023 | P · Purchase | +25.91K | 3.86 | — | 25.91K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20.00
Total
20.00 indirect20.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.00 | Indirect |
| Total | 20.00 | 20.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported